Deepika Pakianathan - Net Worth and Insider Trading
Deepika Pakianathan Net Worth
The estimated net worth of Deepika Pakianathan is at least $4 Million dollars as of 2024-05-13. Deepika Pakianathan is the Director of Karyopharm Therapeutics Inc and owns about 1,724,222 shares of Karyopharm Therapeutics Inc (KPTI) stock worth over $2 Million. Deepika Pakianathan is the Director of OncoMed Pharmaceuticals Inc and owns about 2,010,542 shares of OncoMed Pharmaceuticals Inc (OMED) stock worth over $2 Million. Deepika Pakianathan is also the Director of Calithera Biosciences Inc and owns about 0 shares of Calithera Biosciences Inc (CALA) stock worth over $0. Details can be seen in Deepika Pakianathan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Deepika Pakianathan has not made any transactions after 2023-01-27 and currently still holds the listed stock(s).
Transaction Summary of Deepika Pakianathan
Deepika Pakianathan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Deepika Pakianathan owns 12 companies in total, including FS Development Corp (FSDC) , Theravance Biopharma Inc (TBPH) , and Calithera Biosciences Inc (CALA) among others .
Click here to see the complete history of Deepika Pakianathan’s form 4 insider trades.
Insider Ownership Summary of Deepika Pakianathan
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
FSDC | FS Development Corp | 2020-08-11 | director |
TBPH | Theravance Biopharma Inc | 2020-07-01 | director |
CALA | Calithera Biosciences Inc | 2023-01-27 | director & 10 percent owner |
2022-06-10 | director | ||
2019-04-23 | director | ||
2018-05-23 | director | ||
2016-06-21 | director | ||
2016-03-17 | 10 percent owner | ||
2016-02-03 | 10 percent owner | ||
2013-11-13 | 10 percent owner | ||
2020-08-11 | director | ||
2021-02-16 | director |
Deepika Pakianathan Latest Holdings Summary
Deepika Pakianathan currently owns a total of 3 stocks. Among these stocks, Deepika Pakianathan owns 1,724,222 shares of Karyopharm Therapeutics Inc (KPTI) as of June 10, 2022, with a value of $2 Million and a weighting of 51.23%. Deepika Pakianathan owns 2,010,542 shares of OncoMed Pharmaceuticals Inc (OMED) as of August 21, 2014, with a value of $2 Million and a weighting of 48.77%. Deepika Pakianathan also owns 0 shares of Calithera Biosciences Inc (CALA) as of January 27, 2023, with a value of $0 and a weighting of 0%.
Latest Holdings of Deepika Pakianathan
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
KPTI | Karyopharm Therapeutics Inc | 2022-06-10 | 1,724,222 | 1.09 | 1,879,402 |
OMED | OncoMed Pharmaceuticals Inc | 2014-08-21 | 2,010,542 | 0.89 | 1,789,382 |
CALA | Calithera Biosciences Inc | 2023-01-27 | 0 | 0.02 | 0 |
Holding Weightings of Deepika Pakianathan
Deepika Pakianathan Form 4 Trading Tracker
According to the SEC Form 4 filings, Deepika Pakianathan has made a total of 1 transactions in Karyopharm Therapeutics Inc (KPTI) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Karyopharm Therapeutics Inc is the sale of 538,784 shares on June 10, 2022, which brought Deepika Pakianathan around $3 Million.
According to the SEC Form 4 filings, Deepika Pakianathan has made a total of 0 transactions in OncoMed Pharmaceuticals Inc (OMED) over the past 5 years. The most-recent trade in OncoMed Pharmaceuticals Inc is the acquisition of 80,203 shares on August 21, 2014, which cost Deepika Pakianathan around $2 Million.
According to the SEC Form 4 filings, Deepika Pakianathan has made a total of 1 transactions in Calithera Biosciences Inc (CALA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Calithera Biosciences Inc is the sale of 121,333 shares on January 27, 2023, which brought Deepika Pakianathan around $47,320.
Insider Trading History of Deepika Pakianathan
- 1
Deepika Pakianathan Trading Performance
GuruFocus tracks the stock performance after each of Deepika Pakianathan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Deepika Pakianathan is 32.52%. GuruFocus also compares Deepika Pakianathan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Deepika Pakianathan within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Deepika Pakianathan's insider trading performs compared to the benchmark.
Performance of Deepika Pakianathan
Deepika Pakianathan Ownership Network
Ownership Network List of Deepika Pakianathan
Ownership Network Relation of Deepika Pakianathan
Deepika Pakianathan Owned Company Details
What does FS Development Corp do?
Who are the key executives at FS Development Corp?
Deepika Pakianathan is the director of FS Development Corp. Other key executives at FS Development Corp include director & 10 percent owner & President & CEO James B. Tananbaum , 10 percent owner Foresite Capital Fund V, L.p. , and 10 percent owner Foresite Capital Management V, Llc .
FS Development Corp (FSDC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of FS Development Corp (FSDC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of FS Development Corp (FSDC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
FS Development Corp (FSDC)'s detailed insider trading history can be found in Insider Trading Tracker table.
FS Development Corp Insider Transactions
Deepika Pakianathan Mailing Address
Above is the net worth, insider trading, and ownership report for Deepika Pakianathan. You might contact Deepika Pakianathan via mailing address: 160 Bovet Road, Suite 408, C/o Delphi Ventures, San Mateo Ca 94402.